1079 related articles for article (PubMed ID: 15063124)
1. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus.
Reimann I; Depner K; Trapp S; Beer M
Virology; 2004 Apr; 322(1):143-57. PubMed ID: 15063124
[TBL] [Abstract][Full Text] [Related]
2. CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV).
Koenig P; Lange E; Reimann I; Beer M
Vaccine; 2007 Apr; 25(17):3391-9. PubMed ID: 17257713
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope.
Reimann I; Depner K; Utke K; Leifer I; Lange E; Beer M
Vet Microbiol; 2010 Apr; 142(1-2):45-50. PubMed ID: 19892497
[TBL] [Abstract][Full Text] [Related]
4. Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies.
Aebischer A; Müller M; Hofmann MA
Vet Microbiol; 2013 Jan; 161(3-4):274-85. PubMed ID: 22902189
[TBL] [Abstract][Full Text] [Related]
5. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.
Maurer R; Stettler P; Ruggli N; Hofmann MA; Tratschin JD
Vaccine; 2005 May; 23(25):3318-28. PubMed ID: 15837238
[TBL] [Abstract][Full Text] [Related]
6. Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization.
Leifer I; Lange E; Reimann I; Blome S; Juanola S; Duran JP; Beer M
Vaccine; 2009 Nov; 27(47):6522-9. PubMed ID: 19732859
[TBL] [Abstract][Full Text] [Related]
7. Classical swine fever virus replicon particles lacking the Erns gene: a potential marker vaccine for intradermal application.
Frey CF; Bauhofer O; Ruggli N; Summerfield A; Hofmann MA; Tratschin JD
Vet Res; 2006; 37(5):655-70. PubMed ID: 16777037
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of marker vaccine candidate CP7_E2alf in piglets with maternally derived C-strain antibodies.
Rangelova D; Nielsen J; Strandbygaard B; Koenen F; Blome S; Uttenthal A
Vaccine; 2012 Oct; 30(45):6376-81. PubMed ID: 22939909
[TBL] [Abstract][Full Text] [Related]
9. Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-Duration of immunity.
Gabriel C; Blome S; Urniza A; Juanola S; Koenen F; Beer M
Vaccine; 2012 Apr; 30(19):2928-36. PubMed ID: 22406108
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics.
Eblé PL; Geurts Y; Quak S; Moonen-Leusen HW; Blome S; Hofmann MA; Koenen F; Beer M; Loeffen WLA
Vet Microbiol; 2013 Mar; 162(2-4):437-446. PubMed ID: 23238022
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Suvaxyn CSF Marker (CP7_E2alf) in the presence of pre-existing antibodies against Bovine viral diarrhea virus type 1.
Dräger C; Schröder C; König P; Tegtmeyer B; Beer M; Blome S
Vaccine; 2016 Sep; 34(39):4666-4671. PubMed ID: 27523739
[TBL] [Abstract][Full Text] [Related]
12. Innocuousness and safety of classical swine fever marker vaccine candidate CP7_E2alf in non-target and target species.
König P; Blome S; Gabriel C; Reimann I; Beer M
Vaccine; 2011 Dec; 30(1):5-8. PubMed ID: 22064266
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.
Blome S; Gabriel C; Schmeiser S; Meyer D; Meindl-Böhmer A; Koenen F; Beer M
Vet Microbiol; 2014 Feb; 169(1-2):8-17. PubMed ID: 24411658
[TBL] [Abstract][Full Text] [Related]
14. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
Voigt H; Merant C; Wienhold D; Braun A; Hutet E; Le Potier MF; Saalmüller A; Pfaff E; Büttner M
Vaccine; 2007 Aug; 25(31):5915-26. PubMed ID: 17600594
[TBL] [Abstract][Full Text] [Related]
15. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F
Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536
[TBL] [Abstract][Full Text] [Related]
16. DIVA vaccine properties of the live chimeric pestivirus strain CP7_E2gif.
von Rosen T; Rangelova D; Nielsen J; Rasmussen TB; Uttenthal Å
Vet Microbiol; 2014 Jun; 170(3-4):224-31. PubMed ID: 24629779
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an Erns-based enzyme-linked immunosorbent assay to distinguish Classical swine fever virus-infected pigs from pigs vaccinated with CP7_E2alf.
Pannhorst K; Fröhlich A; Staubach C; Meyer D; Blome S; Becher P
J Vet Diagn Invest; 2015 Jul; 27(4):449-60. PubMed ID: 26179095
[TBL] [Abstract][Full Text] [Related]
18. Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response.
van Gennip HG; van Rijn PA; Widjojoatmodjo MN; de Smit AJ; Moormann RJ
Vaccine; 2000 Oct; 19(4-5):447-59. PubMed ID: 11027808
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of CSF vaccine CP7_E2alf in piglets with maternally derived antibodies.
Eblé PL; Quak S; Geurts Y; Moonen-Leusen HW; Loeffen WL
Vet Microbiol; 2014 Nov; 174(1-2):27-38. PubMed ID: 25265929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
